| UniProt ID | SELPL_HUMAN | |
|---|---|---|
| UniProt AC | Q14242 | |
| Protein Name | P-selectin glycoprotein ligand 1 | |
| Gene Name | SELPLG | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 412 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
| Protein Description | A SLe(x)-type proteoglycan, which through high affinity, calcium-dependent interactions with E-, P- and L-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture.; (Microbial infection) Acts as a receptor for enterovirus 71.. | |
| Protein Sequence | MPLQLLLLLILLGPGNSLQLWDTWADEAEKALGPLLARDRRQATEYEYLDYDFLPETEPPEMLRNSTDTTPLTGPGTPESTTVEPAARRSTGLDAGGAVTELTTELANMGNLSTDSAAMEIQTTQPAATEAQTTQPVPTEAQTTPLAATEAQTTRLTATEAQTTPLAATEAQTTPPAATEAQTTQPTGLEAQTTAPAAMEAQTTAPAAMEAQTTPPAAMEAQTTQTTAMEAQTTAPEATEAQTTQPTATEAQTTPLAAMEALSTEPSATEALSMEPTTKRGLFIPFSVSSVTHKGIPMAASNLSVNYPVGAPDHISVKQCLLAILILALVATIFFVCTVVLAVRLSRKGHMYPVRNYSPTEMVCISSLLPDGGEGPSATANGGLSKAKSPGLTPEPREDREGDDLTLHSFLP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 42 | Pyrrolidone_carboxylic_acid | LLARDRRQATEYEYL HHHHHHHHCCEEEEC | 54.23 | - | |
| 42 | Pyrrolidone_carboxylic_acid | LLARDRRQATEYEYL HHHHHHHHCCEEEEC | 54.23 | 11081633 | |
| 42 | Pyrrolidone_carboxylic_acid | LLARDRRQATEYEYL HHHHHHHHCCEEEEC | 54.23 | 11081633 | |
| 46 | Sulfation | DRRQATEYEYLDYDF HHHHCCEEEECCCCC | 12.91 | - | |
| 46 | Sulfation | DRRQATEYEYLDYDF HHHHCCEEEECCCCC | 12.91 | 11081633 | |
| 48 | Sulfation | RQATEYEYLDYDFLP HHCCEEEECCCCCCC | 12.17 | - | |
| 48 | Sulfation | RQATEYEYLDYDFLP HHCCEEEECCCCCCC | 12.17 | 11081633 | |
| 51 | Sulfation | TEYEYLDYDFLPETE CEEEECCCCCCCCCC | 13.14 | - | |
| 51 | Sulfation | TEYEYLDYDFLPETE CEEEECCCCCCCCCC | 13.14 | 11081633 | |
| 57 | O-linked_Glycosylation | DYDFLPETEPPEMLR CCCCCCCCCCHHHHC | 52.42 | 11081633 | |
| 65 | N-linked_Glycosylation | EPPEMLRNSTDTTPL CCHHHHCCCCCCCCC | 45.35 | UniProtKB CARBOHYD | |
| 67 | Phosphorylation | PEMLRNSTDTTPLTG HHHHCCCCCCCCCCC | 40.70 | - | |
| 69 | Phosphorylation | MLRNSTDTTPLTGPG HHCCCCCCCCCCCCC | 30.33 | - | |
| 73 | Phosphorylation | STDTTPLTGPGTPES CCCCCCCCCCCCCCC | 42.40 | - | |
| 81 | Phosphorylation | GPGTPESTTVEPAAR CCCCCCCCCCCCHHH | 32.95 | - | |
| 82 | Phosphorylation | PGTPESTTVEPAARR CCCCCCCCCCCHHHH | 31.95 | - | |
| 111 | N-linked_Glycosylation | TELANMGNLSTDSAA HHHHHCCCCCCCCHH | 21.76 | UniProtKB CARBOHYD | |
| 143 | O-linked_Glycosylation | PVPTEAQTTPLAATE CCCCCCCCCCCCCCC | 37.11 | OGP | |
| 157 | Phosphorylation | EAQTTRLTATEAQTT CCHHCCEECCCCCCC | 28.39 | - | |
| 159 | Phosphorylation | QTTRLTATEAQTTPL HHCCEECCCCCCCCC | 26.98 | - | |
| 264 | O-linked_Glycosylation | AAMEALSTEPSATEA HHHHHHCCCCCHHHH | 53.41 | OGP | |
| 287 | O-linked_Glycosylation | RGLFIPFSVSSVTHK CCEEECEECCCEECC | 18.74 | 55824305 | |
| 289 | O-linked_Glycosylation | LFIPFSVSSVTHKGI EEECEECCCEECCCC | 20.21 | 55824309 | |
| 290 | O-linked_Glycosylation | FIPFSVSSVTHKGIP EECEECCCEECCCCC | 28.95 | 55824313 | |
| 292 | O-linked_Glycosylation | PFSVSSVTHKGIPMA CEECCCEECCCCCCC | 21.59 | 55824319 | |
| 302 | N-linked_Glycosylation | GIPMAASNLSVNYPV CCCCCCCCEEECCCC | 31.44 | UniProtKB CARBOHYD | |
| 357 | Phosphorylation | HMYPVRNYSPTEMVC CCEECCCCCCCCEEE | 12.88 | 28464451 | |
| 358 | Phosphorylation | MYPVRNYSPTEMVCI CEECCCCCCCCEEEE | 28.97 | 28464451 | |
| 360 | Phosphorylation | PVRNYSPTEMVCISS ECCCCCCCCEEEEEC | 30.67 | 26657352 | |
| 366 | Phosphorylation | PTEMVCISSLLPDGG CCCEEEEECCCCCCC | 15.14 | 28450419 | |
| 367 | Phosphorylation | TEMVCISSLLPDGGE CCEEEEECCCCCCCC | 17.64 | 28464451 | |
| 376 | Phosphorylation | LPDGGEGPSATANGG CCCCCCCCCCCCCCC | 19.25 | 27251275 | |
| 377 | Phosphorylation | PDGGEGPSATANGGL CCCCCCCCCCCCCCC | 49.46 | 26074081 | |
| 379 | Phosphorylation | GGEGPSATANGGLSK CCCCCCCCCCCCCCC | 25.62 | 27080861 | |
| 385 | Phosphorylation | ATANGGLSKAKSPGL CCCCCCCCCCCCCCC | 33.57 | 26074081 | |
| 388 | Ubiquitination | NGGLSKAKSPGLTPE CCCCCCCCCCCCCCC | 62.00 | 29967540 | |
| 389 | Phosphorylation | GGLSKAKSPGLTPEP CCCCCCCCCCCCCCC | 29.12 | 25159151 | |
| 393 | Phosphorylation | KAKSPGLTPEPREDR CCCCCCCCCCCCCCC | 31.36 | 23401153 | |
| 404 | Ubiquitination | REDREGDDLTLHSFL CCCCCCCCCCCHHCC | 53.03 | 29967540 | |
| 405 | Phosphorylation | EDREGDDLTLHSFLP CCCCCCCCCCHHCCC | 6.98 | 27251275 | |
| 406 | Phosphorylation | DREGDDLTLHSFLP- CCCCCCCCCHHCCC- | 29.44 | 28122231 | |
| 409 | Phosphorylation | GDDLTLHSFLP---- CCCCCCHHCCC---- | 31.43 | 23401153 | |
| 422 | Phosphorylation | ----------------- ----------------- | 24719451 | ||
| 425 | Phosphorylation | -------------------- -------------------- | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SELPL_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SELPL_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SELPL_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SELPL_HUMAN | SELPLG | physical | 10713099 | |
| LYAM3_HUMAN | SELP | physical | 10713099 | |
| MOES_HUMAN | MSN | physical | 12115638 | |
| TNIP1_HUMAN | TNIP1 | physical | 17632516 | |
| P85A_HUMAN | PIK3R1 | physical | 17632516 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| O-linked Glycosylation | |
| Reference | PubMed |
| "Insights into the molecular basis of leukocyte tethering and rollingrevealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1."; Somers W.S., Tang J., Shaw G.D., Camphausen R.T.; Cell 103:467-479(2000). Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 42-68 IN COMPLEX WITH SELEAND SELP LECTIN/EGF DOMAINS, SULFATION AT TYR-46; TYR-48 AND TYR-51,GLYCOSYLATION AT THR-57, AND PYROGLUTAMATE FORMATION AT GLN-42. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND THR-393, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND THR-393, ANDMASS SPECTROMETRY. | |
| Sulfation | |
| Reference | PubMed |
| "Insights into the molecular basis of leukocyte tethering and rollingrevealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1."; Somers W.S., Tang J., Shaw G.D., Camphausen R.T.; Cell 103:467-479(2000). Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 42-68 IN COMPLEX WITH SELEAND SELP LECTIN/EGF DOMAINS, SULFATION AT TYR-46; TYR-48 AND TYR-51,GLYCOSYLATION AT THR-57, AND PYROGLUTAMATE FORMATION AT GLN-42. | |